CLINICAL TRIAL COMPLIANCE & OPERATIONS TECHNOLOGY INSIGHTS
-
What Is Shadow AI, And How Does It Impact Clinical Trial Tech?
Discover how shadow AI appears in clinical trial technology and learn how to develop a practical control plan that protects participants and data without slowing innovation.
-
Will AI And Agile Project Management Help Advance RBM?
Will AI-based tools embedded into risk based-monitoring prompt an Agile project management moment for clinical research? Sidharth Ananthanarayan explains why AI-based tools are not the answer but part of it.
IRT RESOURCES
-
Joe Dustin shows why custom integrations do not scale and why standards are essential for efficiently connecting many sites.
-
Shipping and storing leading-edge therapeutics require complex logistics, but enhanced automation and process simplification ensure that sites and patients have the drugs they need when they need them.
-
Learn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
RBQM RESOURCES
-
Joe Dustin shows why custom integrations do not scale and why standards are essential for efficiently connecting many sites.
-
Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.
-
Joe Dustin explains why validation documentation and sponsor benefit are key to getting approval for site-system integration.
RTSM RESOURCES
-
Joe Dustin shows why custom integrations do not scale and why standards are essential for efficiently connecting many sites.
-
Adaptive basket trials need real-time data to close underperforming cohorts fast. See how automation closes that gap and protects patients.
-
Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
EREG RESOURCES
-
A clear guide to U.S. coverage, regulation, and reimbursement: who decides care, how products gain access, and how policy and financing shape cost, value, and patient access.
-
Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).
-
Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.
PAYMENT RESOURCES
-
Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.
-
Global insights show how travel demands, uneven compensation, and overlooked caregiver burden undermine trial participation — making flexible, patient-centered approaches essential.
-
How can you leverage customizable, simplified payment methods and third-party providers to improve patient convenience in your clinical trial?
IRT SOLUTIONS
RBQM SOLUTIONS
RTSM SOLUTIONS
EREG SOLUTIONS
-
Beth Harper explains why the real problem is broader than eSource and why sponsors should integrate around the systems sites already use.
-
Rosie Filling says sponsors should stop guessing and ask sites what tech they use so teams can design with sites, not just for them.
-
Joe Dustin shows why custom integrations do not scale and why standards are essential for efficiently connecting many sites.
PAYMENT SOLUTIONS
-
Joe Dustin shows why custom integrations do not scale and why standards are essential for efficiently connecting many sites.
-
Joe Dustin explains why validation documentation and sponsor benefit are key to getting approval for site-system integration.
-
Integrate data from all industry sources to confidently plan budgets for studies worldwide, across all phases and therapeutic areas.